Nicorandil to improve small blood vessel function after a heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a medicine called nicorandil can improve blood flow in small heart blood vessels after a heart attack, when given during the procedure to open the blocked artery. If you qualify, you may receive this extra treatment to help your heart recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a heart attack (STEMI) and are about to have a procedure to open the blocked artery (primary PCI).
- The blocked artery that caused the heart attack is large enough (wider than 2 mm) to be treated with a stent.
- You have not taken the study medicine nicorandil in the last month.
- You do not have severe liver or kidney disease, and you are not in cardiogenic shock.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.
This study tests a medicine called nicorandil, which is normally used for chest pain, to see if it can lower the risk of heart disease in people with rheumatoid arthritis. If you have RA and are already on standard treatment, this may help protect your heart.
This study tests whether nicorandil, a heart medication with anti-inflammatory properties, can help reduce joint inflammation and swelling in people with active rheumatoid arthritis who are already taking conventional disease-modifying drugs. The goal is to see if it provides additional relief from symptoms.
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
Hear when a new STEMI - ST-segment Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.